Prime Therapeutics welcomes new client success leader
DeZearn to lead our client teams and help ensure Prime’s client relationships are collaborative, accountable, responsive and alignedApril 26, 2021
As vice president of client success, DeZearn is responsible for leading our client teams and helping to ensure Prime’s client relationships are collaborative, accountable, responsive and aligned. DeZearn is a licensed clinical pharmacist and has extensive pharmacy benefit management industry experience with sales and account management.
In her nearly 30-year career, DeZearn has led clinical and sales/account management teams at Diversified Pharmaceutical Services, Merck-Medco Managed Care, Medco Health Solutions, Anthem and most recently, Express Scripts. She has led initiatives in benefit design, clinical and formulary management aimed at lowering overall drug costs.
“Karen is a team-oriented, metric driven leader who possesses the skills needed for Prime to continue to evolve its client relationships to be more strategic and mutually beneficial,” said Dave Schlett, chief financial officer.
DeZearn holds a Doctor of Pharmacy degree from Campbell University School of Pharmacy in North Carolina.
June 2, 2022
Prime Therapeutics finds $1.1 million waste reduction opportunity with medically integrated dispensing compared to central specialty pharmacy
EAGAN, Minn. – Leading pharmacy benefit manager (PBM) Prime Therapeutics LLC (Prime) analyzed…
May 23, 2022
Prime Therapeutics’ MedDrive™ program leverages biosimilars to cut member drug expenses by 26% in one year
EAGAN, Minn. – Prime Therapeutics LLC (Prime) announced that its MedDrive™ program achieved…
May 5, 2022
Prime Therapeutics is acquiring Magellan Rx to advance integrated specialty drug management, accelerating efforts to lower the cost of drugs and improve health outcomes
EAGAN, Minn. – Pharmacy benefit manager Prime Therapeutics LLC (Prime) on May 3…